Key result
Cardiac resynchronisation therapy implantation is feasible and safe in very elderly patients despite extensive co-morbidity, though retrospective data limits detailed subgroup analyses.
Why the study?
Is cardiac resynchronisation therapy feasible and safe in very elderly patients?
Is cardiac resynchronisation therapy feasible and safe in very elderly patients?
Answers are grounded in this paper and cite their sources.
This letter highlights findings that CRT implantation is feasible and safe in very elderly patients despite extensive comorbidities.
I have read the article entitled “Is cardiac resynchronisation therapy feasible, safe and beneficial in the very elderly?” by Olechowski, et al.[1] with great interest, recently published in Journal of Geriatric Cardiology. The investigators reported that implantation of cardiac resynchronisation therapy (CRT) is feasible and safe in very elderly despite extensive co-morbidity.[1]
No takes yet. Share an insight, caveat, or question.
Levent Ceri̇t (2016) conducted a letter in Heart failure. Cardiac resynchronisation therapy (CRT) was evaluated on Complication rate for device implants according to age. Cardiac resynchronisation therapy implantation is feasible and safe in very elderly patients despite extensive co-morbidity, though retrospective data limits detailed subgroup analyses.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: